申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2015180614A1
公开(公告)日:2015-12-03
The preseent invention relates to novel retinoid-related orphan receptor gamma(RORγ)modulators and their use in the treatment ofdiseases mediated by RORγ.
本发明涉及新型视黄醇相关孤儿受体γ(RORγ)调节剂及其在通过RORγ介导的疾病治疗中的应用。